The plasma CCL22 levels in patients with FIGO stage IV of ovarian cancer was significantly higher than in women with FIGO stage I (p = 0.003) and FIGO stage III (p = 0.02) (Fig. 1). The gene discussed is CCL22; the disease is ovarian cancer.